Research study of sitagliptin and miglitol on type 2 diabetes patients during insulin administration

Research study of sitagliptin and miglitol on type 2 diabetes patients during insulin administration - Research study of sitagliptin and miglitol on type 2 diabetes patients during insulin administration

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007706

Enrollment

Registered

2012-04-10

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 diabetes mellitus

Interventions

Research study of sitagliptin and miglitol on type 2 diabetes patients during insulin administration Research study of sitagliptin and miglitol on type 2 diabetes patients during insulin administratio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Type 2 diabetes who show postprandial hyperglycemia. 6.5% < HbA1c(JDS) < 8.5%

Exclusion criteria

Exclusion criteria: The exclusion criteria were patients who had taken glinid and sulfonylurea, type 1 diabetes, current history of diabetic ketoacidosis or diabetic come, and/or cerebral stroke, renal insufficiency (serum creatinnin > 1.5 in men, serum creatinin > 1.3 in women, sever infection, current history of operation or trauma, patients with hypersensitive for sitagliptin or miglitol, expectant mother, lactating woman, an age < 20, inappropriate patients judged by the physician in charge

Design outcomes

Primary

Measure	Time frame
The blood glucose fluctuations after meal test and vascular endothelial dysfunction	—

Countries

Japan

Contacts

Public ContactMinoru Takemoto

Chiba University Hospital Department of Medicine, Division of Diabetes, Metabolism and Endocrinology

minoru.takemoto@faculty.chiba-u.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026